Who owns Aclaris Therapeutics?

Top investors of Aclaris Therapeutics stock

Who bought or sold Aclaris Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Renaissance Technologies 3.4M $8.8M 5% Sep 2020
Adage Capital Partners GP 2.5M $6.4M 0% Sep 2020
Samsara BioCapital 2.2M $5.5M -17% Sep 2020
Rock Springs Capital Management 2.1M $5.3M 26% Sep 2020
Sofinnova Ventures 1.9M $4.9M 0% Sep 2020
Parkman Healthcare Partners 1.8M $4.7M 9% Sep 2020
Vivo Capital 1.6M $4.2M 0% Sep 2020
EcoR1 Capital 1.5M $3.9M 0% Sep 2020
Endurant Capital Management 1.4M $3.7M -17% Sep 2020
Vanguard Group 1.3M $3.3M 0% Sep 2020
BlackRock 1.0M $2.7M 100% Sep 2020

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Aclaris Therapeutics?

Foresite Capital Management III 685k $1.8M 100% Sep 2020
Aisling Capital Management 635k $1.6M 0% Sep 2020
Geode Capital Management 402k $1.0M -3% Sep 2020
J. Goldman & Co 397k $1.0M 100% Sep 2020
Millennium Management 282k $724k -27% Sep 2020
Bridgeway Capital Management 274k $705k 0% Sep 2020
Telemetry Investments 268k $687k -44% Sep 2020
Schonfeld Strategic Advisors 249k $641k 27% Sep 2020
FMR 206k $529k 0% Sep 2020
Acadian Asset Management 194k $499k 105% Sep 2020
Foresite Capital Management IV 145k $372k 100% Sep 2020
Bank of New York Mellon 109k $281k 0% Sep 2020
Invesco 98k $251k -3% Sep 2020
Northern Trust 96k $261k -3% Sep 2020
State Street Corporation 78k $201k 0% Sep 2020
Deutsche Bank Aktiengesellschaft 66k $169k 0% Sep 2020
Alambic Investment Management 60k $154k -34% Sep 2020
HighTower Advisors 60k $153k -14% Sep 2020
Winton Capital 48k $122k 5% Sep 2020
Cambridge Investment Research Advisors 45k $115k 0% Sep 2020
Citadel Advisors 39k $102k 100% Sep 2020
Connor, Clark & Lunn Investment Management 32k $81k 100% Sep 2020
Creative Planning 30k $77k 0% Sep 2020
Jane Street 30k $76k -85% Sep 2020
Goldman Sachs Group 26k $68k -25% Sep 2020
Two Sigma Advisers 23k $60k -10% Sep 2020
Tudor Investment Corporation 21k $53k -65% Sep 2020
Charles Schwab Investment Management 21k $53k 0% Sep 2020
Morgan Stanley 20k $52k 50% Sep 2020
Dimensional Fund Advisors 19k $48k 63% Sep 2020
Susquehanna International 12k $31k 100% Sep 2020
LMR Partners 11k $29k -15% Sep 2020
Group One Trading 7.6k $20k 204% Sep 2020
UBS Group 5.0k $13k 817% Sep 2020
Cutler 4.1k $10k 21% Sep 2020
Advisor Group Holdings 4.0k $10k 100% Sep 2020
Parallel Advisors 3.9k $10k 0% Sep 2020
Simplex Trading 3.2k $7.990000 521% Sep 2020
Federated Investors 2.4k $6.0k -6% Sep 2020
O'shaughnessy Asset Management 1.4k $3.0k 0% Sep 2020
Wells Fargo & Company 1.2k $5.6k -46% Sep 2020
Northwestern Mutual Wealth Management Company 500.00 $1.0k 0% Sep 2020
Royal Bank of Canada 374.00 $1.0k -92% Sep 2020
Ellevest 135.00 $0 0% Sep 2020
Bank of America Corporation 44.00 $0 -99% Sep 2020
Jpmorgan Chase & Co 37.00 $0 0% Sep 2020
Barclays 18.00 $0 -100% Sep 2020

Who sold out of Aclaris Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
MFN Partners Management Jun 2020 3.3M $5.4M
Old Mission Capital Jun 2020 95k $154k
Man Group Jun 2020 94k $151k
Sunrise Partners Limited Partnership Jun 2020 72k $116k
Verition Fund Management Jun 2020 65k $105k
Virtu Financial Jun 2020 37k $61k
Aperio Group Jun 2020 21k $37k
Bnp Paribas Arbitrage, Snc Jun 2020 11k $17k
Springbok Capital Management Jun 2020 375.00 $1.0k
Glenmede Trust Company Jun 2020 74.00 $0